Peripheral Demyelinating Neuropathy, Central Dysmyelination, Waardenburg Syndrome, and Hirschsprung Disease
|
0.930 |
GeneticVariation
|
disease |
BEFREE |
Most PCWH-associated SOX10 mutations result in premature termination codons (PTCs), for which the molecular mechanism has recently been delineated.
|
17855451 |
2007 |
Peripheral Demyelinating Neuropathy, Central Dysmyelination, Waardenburg Syndrome, and Hirschsprung Disease
|
0.930 |
GeneticVariation
|
disease |
BEFREE |
We present a 4-year-old girl with the PCWH phenotype associated with a de novo nonsense mutation (S384X) in SOX10.
|
16504559 |
2006 |
Peripheral Demyelinating Neuropathy, Central Dysmyelination, Waardenburg Syndrome, and Hirschsprung Disease
|
0.930 |
GeneticVariation
|
disease |
BEFREE |
We suggest that hypoganglionosis can be a variant intestinal manifestation associated with PCWH and that hypoganglionosis and aganglionosis may share the same pathoetiological mechanism mediated by SOX10 mutations.
|
29681101 |
2018 |
Waardenburg Syndrome
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
This is the first truncating mutation in exon 3 of SOX10 that is associated with neurological symptoms in Waardenburg syndrome.
|
29792164 |
2018 |
Waardenburg Syndrome
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Our result conform the thesis that heterozygous deletions at SOX10 is an important pathogenicity for WS, and present as autosomal dominant inheritance.
|
26296878 |
2015 |
Waardenburg Syndrome
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Abnormalities in SOX10 are associated with Waardenburg syndrome Types II and IV, and these patients have recognizable clinical features.
|
29216801 |
2018 |
Waardenburg Syndrome
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Lately it has been suggested that whole SOX10 gene deletions can be encountered when testing for WS.
|
22842075 |
2012 |
Waardenburg Syndrome
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Mutations in SOX10, one of the genes contributing to syndromic hearing loss, induce a large range of phenotypes, including several subtypes of Waardenburg syndrome and Kallmann syndrome with deafness.
|
25256313 |
2015 |
Waardenburg Syndrome
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Human SOX10 mutations lead to various diseases including Waardenburg syndrome, Hirschsprung disease, peripheral demyelinating neuropathy, central leukodystrophy, Kallmann syndrome and various combinations thereof.
|
29361054 |
2018 |
Waardenburg Syndrome
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Molecular analysis detected a de novo p.Leu145Pro mutation in SOX10, which has previously been reported in a patient with WS and Hirschsprung disease.
|
26228106 |
2015 |
Waardenburg Syndrome
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Recently, we identified some novel WS-associated mutations in PAX3 and SOX10 in a cohort of Chinese WS patients.
|
21965087 |
2012 |
Waardenburg Syndrome
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
While type I is tightly associated to PAX3 mutations, WS type II (WS2) remains partly enigmatic with mutations in known genes (MITF, SOX10) accounting for only 30% of the cases.
|
28236341 |
2017 |
Waardenburg Syndrome
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Chronic constipation may be recognized as indicative of a SOX10 mutation in patients with Waardenburg syndrome.
|
24582978 |
2014 |
Waardenburg Syndrome
|
0.600 |
Biomarker
|
disease |
BEFREE |
This study adds to the existing body of knowledge by characterizing a 2.4 Mb deletion [arr[hg19] 22q12.3-q13.1 (36467502-38878207)x1] encompassing SOX10 and 53 additional RefSeq genes in a 15-year-old female with atypical WS.
|
24715709 |
2014 |
Waardenburg Syndrome
|
0.600 |
Biomarker
|
disease |
BEFREE |
Many genes have been linked to WS, including PAX3, MITF, SNAI2, EDNRB, EDN3, and SOX10, and many additional genes have been associated with disorders with phenotypic overlap with WS.
|
25932447 |
2015 |
Waardenburg Syndrome
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Deletions at the SOX10 gene locus cause Waardenburg syndrome types 2 and 4.
|
17999358 |
2007 |
Waardenburg Syndrome
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Children presenting with features of Waardenburg syndrome and neurological dysfunction should be tested for mutations in the SOX10 gene to enable diagnosis and counselling.
|
16504559 |
2006 |
Waardenburg Syndrome
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Mutations in the endothelin-3 (EDN3), endothelin-B receptor (EDNRB), and Sox10 genes have been identified as causative for WS type IV.
|
10528251 |
1999 |
Waardenburg Syndrome
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
SOX10 mutations are usually associated with a more severe phenotype of WS with peripheral demyelinating neuropathy, central dysmyelinating leukodystrophy, and Hirschsprung disease.
|
28544110 |
2017 |
Waardenburg Syndrome
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Novel mutations in the SOX10 gene in the first two Chinese cases of type IV Waardenburg syndrome.
|
21531202 |
2011 |
Waardenburg Syndrome
|
0.600 |
Biomarker
|
disease |
BEFREE |
As genetic background affects WS severity in both humans and mice, we established an N-ethyl-N-nitrosourea (ENU) mutagenesis screen to identify modifiers that increase the phenotypic severity of Sox10(LacZ/+) mice.
|
18397875 |
2008 |
Waardenburg Syndrome
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
The recent identification of a deletion encompassing three of the SOX10 regulatory elements in a patient presenting with another WS subtype, WS4, defined by its association with Hirschsprung disease, led us to search for deletions and point mutations within the MITF and SOX10 regulatory elements in 28 yet unexplained WS2 cases.
|
22848661 |
2012 |
Waardenburg Syndrome
|
0.600 |
Biomarker
|
disease |
BEFREE |
Clinical re-evaluation of these probands shows that some of them have subtle syndromic findings, while none of them meets clinical criteria for the diagnosis of the associated syndrome (Waardenburg (SOX10 and MITF), Kallmann (CHD7 and SOX10), Noonan/LEOPARD (PTPN11), CHARGE (CHD7), or Kabuki (KMT2D).
|
27562378 |
2016 |
Waardenburg Syndrome
|
0.600 |
AlteredExpression
|
disease |
BEFREE |
SOX10 transcription factor and endothelin receptor type B (EDNRB) are responsible for WS type 4 (WS4), which also exhibits megacolon, while microphthalmia-associated transcription factor (MITF) is responsible for WS2, which is not associated with megacolon.
|
16921166 |
2006 |
Waardenburg Syndrome
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
It has been implicated in Waardenburg syndrome (WS), a rare disorder characterized by the association between pigmentation abnormalities and deafness, but SOX10 mutations cause a variable phenotype that spreads over the initial limits of the syndrome definition.
|
23643381 |
2013 |